AI Drug Firm METiS Is Said Consider $200 Million Hong Kong IPO

Artificial intelligence-driven drug firm METiS Pharmaceuticalsis considering an initial public offering in Hong Kong to raise as much as $200 million, according to people familiar with the matter.

The drug delivery and discovery company is working with advisers to arrange an IPO, potentially before the end of this year, the people said, asking not to be identified because the discussions aren’t public.

Deliberations are ongoing and details such as size and timing may change, the people said.

METiS didn’t respond to requests for comment.

Read More: Chinese Share Sales Keep Going, Shrugging Off Tariffs: ECM Watch

Based in Hangzhou, ...